Satsuma Pharmaceuticals is based out of Durham. Satsuma Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel therapeutic products for the acute treatment of migraine. Satsuma Pharmaceuticals serves customers in the State of California. The firm last filed a Form D notice of exempt offering of securities on 2018-02-12. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
SATSUMA PHARMACEUTICALS, INC.4819 EMPEROR BOULEVARD
DURHAM NC 27703
Business Phone: 415-505-0809
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS